---
title: "九安醫療獲得美國批准用於流感、新冠病毒和呼吸道合胞病毒（RSV）的測試套件"
description: "九安醫療獲得美國批准用於流感、COVID-19 和 RSV 的檢測套件"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/269704763.md"
published_at: "2025-12-15T10:40:42.000Z"
---

# 九安醫療獲得美國批准用於流感、新冠病毒和呼吸道合胞病毒（RSV）的測試套件

> 九安醫療獲得美國批准用於流感、COVID-19 和 RSV 的檢測套件

### Related Stocks

- [002432.CN - 九安醫療](https://longbridge.com/zh-HK/quote/002432.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Andon Health Q3 net profit down 12.8% y/y | Andon Health Q3 net profit down 12.8% y/y | [Link](https://longbridge.com/zh-HK/news/262586289.md) |
| 18:16 ETDiffering immune responses in infants may explain increased severity of RSV over SARS-CoV-2 | A study published in Science Translational Medicine reveals that young infants exhibit differing immune responses to res | [Link](https://longbridge.com/zh-HK/news/276954772.md) |
| Next-generation Influenza Vaccines Could Save Millions Of Lives: WHO | Next-generation influenza vaccines could significantly reduce the global burden of influenza, according to a WHO assessm | [Link](https://longbridge.com/zh-HK/news/276601285.md) |
| LIVE MARKETS-What a US strike on Iran could mean for markets: Carson Group | Main US indexes are down, with the Dow falling over 1%. The S&P 500 is close to all-time highs, but concerns about a pot | [Link](https://longbridge.com/zh-HK/news/277231109.md) |
| 08:03 ETDecentralized Clinical Trial Validates Novel "Fasting Mimetic" Formulation for Cardiometabolic Health | People Science announced a randomized, double-blind, placebo-controlled clinical trial with Mimio Health, published in N | [Link](https://longbridge.com/zh-HK/news/277468910.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。